PRESS RELEASE published on 05/14/2024 at 22:05, 2 years 1 month ago Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension at the European Hematology Association 2024 Congress Protagonist Therapeutics to present rusfertide Phase 2 REVIVE study data at EHA Congress in Madrid. Study shows absence of QTc prolongation with rusfertide. Details on pipeline drugs and collaborations available on company's website Clinical Development Collaborations Protagonist Therapeutics Rusfertide EHA Congress
Published on 06/25/2026 at 15:30, 1 hour 37 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/25/2026 at 15:00, 2 hours 7 minutes ago Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
Published on 06/25/2026 at 14:30, 2 hours 37 minutes ago Unusual Machines Expands Orlando Manufacturing Footprint to Support Battery Operations
Published on 06/25/2026 at 14:01, 3 hours 6 minutes ago Worksport (NASDAQ:WKSP) Regains $1 Bid Price Requirement, Announces CEO Town Hall, Highlights Multiple Recent Growth Drivers in CEO Letter
Published on 06/25/2026 at 14:00, 3 hours 7 minutes ago Horizon Aircraft's Leadership Team to Participate at Farnborough International Airshow 2026
Published on 06/25/2026 at 16:00, 1 hour 7 minutes ago Edison issues report on Worldwide Healthcare Trust (WWH)
Published on 06/25/2026 at 16:00, 1 hour 7 minutes ago Paddles up! Hong Kong marks 50 Years of international dragon boat thrills
Published on 06/25/2026 at 15:47, 1 hour 19 minutes ago Edison issues report on Cordiant Digital Infrastructure (CORD)
Published on 06/25/2026 at 15:26, 1 hour 40 minutes ago Your Family Entertainment AG launches transformation into an Agentic Media Company
Published on 06/25/2026 at 15:10, 1 hour 56 minutes ago Abu Dhabi's cultural vision strikes a new note with landmark performing arts institution Dar al Funoon Abu Dhabi
Published on 06/25/2026 at 15:58, 1 hour 9 minutes ago 260625 BENETEAU Transactions sur actions propres
Published on 06/25/2026 at 07:30, 9 hours 37 minutes ago Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.
Published on 06/25/2026 at 07:30, 9 hours 37 minutes ago Gimv ondertekent een overeenkomst voor de overname van Groupe Cap Vert, de Franse marktleider in multispecialistische essentiële diensten voor het beheer van bomen en groene infrastructuur, van Ambienta.
Published on 06/25/2026 at 07:30, 9 hours 37 minutes ago Gimv signe un accord en vue d’acquérir le Groupe Cap Vert, leader français multi-spécialiste des services de gestion du patrimoine arboré et végétal, auprès d’Ambienta
Published on 06/24/2026 at 19:00, 22 hours 7 minutes ago ALTAREA - Succès de l’option pour le paiement du dividende en actions : taux de souscription de 78,5 %